News

.
/ News, Research

A Step Forward in Precision Medicine: Novel BiTE Immunotherapy for High-Risk CLL (Binder Lab)

Chronic lymphocytic leukemia (CLL) is a malignant B-cell disease whose course is strongly influenced by the configuration of the B-cell receptor (BCR). A well-known high-risk marker is the IGLV3-21-R110 mutation, found in about 10–15% of…

.
/ News, People

ERC Starting Grants Awarded to Four DBM Researchers

"What if we could re-energize exhausted immune cells to fight cancer again? Or slow down the aging process of our immune system? What if we could stop breast cancer from spreading? What if there were better cellular immunotherapies to fight…

.
/ News, People

Welcome to the Team – Marc Busche Lab!

Professor Dr. Marc Aurel Busche has been appointed Clinical Professor of Dementia at the Medical Faculty of the University of Basel, Head of the Memory Clinic and Geriatric Psychiatry Department at the Felix Platter University Hospital, and…

DBM 25 Years
/ News, Events

25 Years of Discovery, Collaboration, and Impact

What began in 2000 as a visionary initiate — to unite fundamental biomedical science and clinical experimental research under one roof — has grown into one of Switzerland’s leading centers for translational biomedical research. Over the…

.
/ News, Research

DBM Research Prize Winner 2024 / 2025

Congratulations to this year’s DBM research prize winner! As we enjoy our annual summer symposium, we would like to recognize Dr. Laurentz Schuhknecht from Mattia Zampieri’s Systems Pharmacology and Biology of Metabolism Lab who has been…

To top